Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography

NCT06022068 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Sirolimus

Sponsor

Karolinska Institutet

Collaborators

[object Object]